Nutraprime 1000 is a meticulously formulated softgel capsule containing 1000mg of evening primrose oil, designed for pharmaceutical-grade consistency and stability. The formulation leverages advanced excipient compatibility testing to ensure optimal dissolution and bioavailability. The softgel matrix is engineered to maintain the integrity of the lipid-based active ingredient, preserving its therapeutic potential during storage and transit. Manufacturing processes focus on minimizing oxidation and moisture ingress, critical for maintaining the efficacy of omega-6 fatty acids. The product’s formulation adheres to strict pharmaceutical standards, ensuring uniformity in weight, disintegration time, and content uniformity. Excipients such as gelatin, glycerin, and antioxidants are selected for their compatibility with evening primrose oil, ensuring no adverse interactions during digestion. The final product is designed for scalability, with formulation parameters optimized for both small-scale development and large-volume production.
Manufacturing Capability
Delwis Healthcare’s pharmaceutical manufacturing infrastructure is equipped to produce Nutraprime 1000 with precision and efficiency. The facility features state-of-the-art softgel encapsulation equipment, including automated filling and sealing systems, ensuring consistent dosing and minimal product wastage. Sterile processing capabilities are maintained through Class 10,000 cleanroom environments, adhering to cGMP (Current Good Manufacturing Practice) standards. All production lines are validated for compliance with ISO 9001 and ISO 14001, ensuring environmental and quality management system excellence. The facility supports scalable production, with the capacity to manufacture bulk quantities while maintaining batch consistency. Quality systems include real-time monitoring of critical parameters such as temperature, humidity, and encapsulation accuracy. Raw material sourcing is strictly controlled, with suppliers audited for compliance with pharmacopeial standards. The manufacturing process is designed to meet the demands of global pharmaceutical buyers, ensuring rapid turnaround without compromising on quality.
Available Strengths and Packaging
Composition: Evening Primrose Oil 1000mg Softgel
Packaging: 10x1x15
Nutraprime 1000 is available in a single strength of 1000mg per softgel, tailored for pharmaceutical and nutraceutical applications. The packaging format of 10x1x15 refers to 10 blister strips, each containing 15 softgels, packaged in a box of 10. This configuration ensures efficient storage, transportation, and retail display, meeting the requirements of bulk supply and distribution. The packaging design is optimized for stability, with moisture-resistant materials and tamper-evident seals to preserve product integrity.
Contract Manufacturing / Third Party Manufacturing
Delwis Healthcare offers comprehensive contract manufacturing and third-party production services for pharmaceutical buyers seeking to source Nutraprime 1000. Our private label manufacturing capabilities allow clients to customize branding, packaging, and labeling to meet regional or market-specific requirements. We support both OEM (Original Equipment Manufacturer) and ODM (Original Design Manufacturer) models, enabling flexibility in product development. For global pharmaceutical suppliers, we provide end-to-end manufacturing solutions, including formulation development, pilot production, and full-scale commercialization. Our team collaborates closely with buyers to align production timelines with regulatory submissions and market launch strategies. Whether sourcing for domestic or international markets, Delwis Healthcare ensures compliance with local and global standards, reducing time-to-market for pharmaceutical and nutraceutical products.
Quality Assurance
Quality assurance for Nutraprime 1000 is built on rigorous testing protocols and adherence to pharmaceutical standards. Each batch undergoes comprehensive analytical validation, including HPLC (High-Performance Liquid Chromatography) for active ingredient quantification, microbial testing for contamination, and physical property assessments such as disintegration time and weight variation. In-process controls monitor critical parameters during encapsulation, ensuring uniformity in fill volume and gelatin integrity. Finished product testing includes stability studies to confirm shelf life under accelerated conditions, as well as dissolution testing to verify bioavailability. All quality control measures are documented in compliance with cGMP, ISO 17025, and pharmacopeial guidelines. Batch records are maintained for traceability, and corrective actions are implemented promptly to address deviations. This systematic approach ensures that Nutraprime 1000 meets the highest standards of safety, efficacy, and consistency for pharmaceutical buyers.
Regulatory Compliance
Delwis Healthcare ensures full compliance with global regulatory frameworks, including cGMP, WHO guidelines, and ISO standards. Nutraprime 1000 is manufactured in facilities certified under ISO 9001 for quality management and ISO 14001 for environmental responsibility. The product adheres to WHO’s guidelines for pharmaceutical excipients and active pharmaceutical ingredients, ensuring suitability for international markets. Regulatory submissions for export are supported by complete documentation, including batch certificates of analysis, stability reports, and compliance statements. The manufacturing process aligns with FDA, EMA, and PIC/S requirements, enabling seamless approval for markets in the EU, North America, and Asia-Pacific. Delwis Healthcare also maintains compliance with local regulatory authorities, ensuring that Nutraprime 1000 meets all legal and safety standards for pharmaceutical supply.
Global Supply Capability
Delwis Healthcare provides robust global supply capabilities, with a well-established international distribution network spanning over 50 countries. Our bulk supply capacity allows for large-volume orders, supporting pharmaceutical buyers’ needs for both domestic and export markets. The supply chain is optimized for reliability, with redundant logistics systems and real-time tracking to ensure timely delivery. Export capabilities include compliance with customs regulations, phytosanitary certificates, and documentation for duty-free clearance. Bulk supply is supported by dedicated warehouse facilities, enabling efficient inventory management and rapid dispatch. Our team works closely with buyers to navigate regional import requirements, ensuring seamless cross-border transactions. Whether sourcing for regional distribution or global expansion, Delwis Healthcare guarantees consistent supply and compliance with international trade standards.
Why Choose Us
Pharmaceutical distributors, exporters, and contract manufacturing partners choose Delwis Healthcare for our unparalleled expertise in nutraceutical and pharmaceutical manufacturing. Our commitment to cGMP, ISO, and WHO compliance ensures that Nutraprime 1000 meets the highest global standards. With scalable production capabilities, we support both small and large orders without compromising quality. Our private label and contract manufacturing services offer flexibility, enabling buyers to customize products for specific markets. Delwis Healthcare’s global supply network and regulatory expertise streamline export processes, reducing time-to-market for pharmaceutical and nutraceutical products. Additionally, our dedicated customer support team provides end-to-end assistance, from formulation development to post-market compliance. By partnering with Delwis Healthcare, buyers gain access to a reliable, compliant, and scalable supplier for Nutraprime 1000.
Bulk Supply Inquiry
Delwis Healthcare offers bulk supply capabilities for Nutraprime 1000, tailored to meet the demands of pharmaceutical buyers. For inquiries regarding bulk orders, please contact our sales team at info@delwishealthcare.com.
FAQs
What certifications does Delwis Healthcare hold for Nutraprime 1000?
Delwis Healthcare is certified under cGMP, ISO 9001, ISO 14001, and WHO guidelines, ensuring compliance with global pharmaceutical standards.
Can Nutraprime 1000 be customized for private label manufacturing?
Yes, we offer private label manufacturing services, allowing customization of branding, packaging, and labeling to meet market-specific requirements.
What is the shelf life of Nutraprime 1000?
Nutraprime 1000 has a shelf life of 24 months when stored under recommended conditions (cool, dry, and away from light).
Does Delwis Healthcare support export to international markets?
Yes, we provide export-ready products with full compliance documentation, enabling seamless clearance in EU, North America, and Asia-Pacific markets.
What quality control measures are in place for Nutraprime 1000?
Each batch undergoes HPLC analysis, microbial testing, and stability studies to ensure safety, efficacy, and consistency.
Can Nutraprime 1000 be produced in bulk quantities?
Yes, our scalable manufacturing infrastructure supports bulk production to meet the demands of pharmaceutical buyers.
What is the packaging configuration for Nutraprime 1000?
Nutraprime 1000 is available in 10x1x15 packaging, comprising 10 blister strips with 15 softgels each, packaged in a box of 10.
How does Delwis Healthcare ensure regulatory compliance for exports?
We maintain full compliance with FDA, EMA, PIC/S, and WHO guidelines, providing all necessary documentation for global regulatory submissions.
What is the minimum order quantity for bulk supply?
Minimum order quantities are flexible and can be tailored to meet the specific needs of pharmaceutical buyers.
How can I contact Delwis Healthcare for bulk supply inquiries?
For bulk supply inquiries, please contact our sales team at **info@delwishealthcare.com**.
